Picton L, Bell JS, George J, et al. - A case-crossover study using medication dispensing data from the Australian Pharmaceutical Benefits Scheme 10% random sample was performed to investigate changes in statin use after initiating medication for managing dementia. The sample consisted of people aged ≥ 65 years who had their first dispensing of anti-dementia medication or risperidone between July 2006 and June 2017 and survived ≥ 12 months after their first supply. Data reported that the cohort included 19,809 participants who had a median age of 81 years and 61% were women. Statins are more likely to be stopped than started following initiation of dementia treatment. This may represent changes in treatment priorities or changes in the understanding of available evidence for the safety and effectiveness of statins in older people living with dementia.